# TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy

> **NCT06013839** · PHASE2 · UNKNOWN · sponsor: **Constant Therapeutics LLC** · enrollment: 10 (estimated)

## Conditions studied

- DMD-Associated Dilated Cardiomyopathy

## Interventions

- **DRUG:** talfirastide

## Key facts

- **NCT ID:** NCT06013839
- **Lead sponsor:** Constant Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-31
- **Primary completion:** 2024-08
- **Final completion:** 2024-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06013839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06013839, "TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06013839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*